Pharmaceutical

Granite Bio secures $100m in funding for new antibodies

Granite Bio has secured $100m in funding for its new antibody treatments that target several autoimmune diseases.

Apr 26, 2025 - 06:00
Granite Bio secures $100m in funding for new antibodies
Granite Bio has secured $100m in funding for its new antibody treatments that target several autoimmune diseases.
Read the original article

Tags:

Previous Article

Caribou cuts pipeline and workforce to focus on lead CAR-T programmes

Next Article

EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Century secures $60m in stock sale and buys preclinical cell therapy biotech

Century secures $60m in stock sale and buys preclinical...

Apr 13, 2024

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

Congenital syphilis cases in the U.S. have skyrocketed,...

Nov 7, 2023

Alumis secures $259m to develop therapies for immune dysfunction

Alumis secures $259m to develop therapies for immune dy...

Mar 7, 2024